Amphastar Pharmaceuticals, Inc. (AMPH)
23.10
+0.22
(+0.96%)
USD |
NASDAQ |
Apr 20, 11:49
Amphastar Pharmaceuticals EPS Diluted (Quarterly) : 0.518 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2345 |
| Dentsply Sirona, Inc. | -0.7315 |
| BioLife Solutions, Inc. | 0.0152 |
| Organon & Co. | -0.7879 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.43M |
| Revenue (Quarterly) | 183.10M |
| Total Expenses (Quarterly) | 158.68M |
| Enterprise Value | 1.409B |
| Gross Profit Margin (Quarterly) | 44.70% |
| Profit Margin (Quarterly) | 13.34% |
| Earnings Yield | 8.80% |
| Operating Earnings Yield | 12.61% |
| Normalized Earnings Yield | 8.514 |